News & Events :: Intensity Therapeutics, Inc. (INTS)

Recent News View All News

Dec 12, 2024 8:00am EST

Intensity Therapeutics, Inc. and The Swiss Group for Clinical Cancer Research SAKK Present Phase 2 Data in Presurgical Breast Cancer from the completed INVINCIBLE-2 Study, and an Overview of the Ongoing Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial, INVINCIBLE-4 (SAKK 66/22), at the 2024 San Antonio Breast Cancer Symposium (SABCS)

Nov 21, 2024 8:00am EST

Intensity Therapeutics, Inc. Announces Pricing of $3 Million Registered Direct Offering and Concurrent Private Placement

Recent Events View IR Calendar

Nov 16 – Dec 31, 2024

2024 Connective Tissue Oncology Society (CTOS)

San Diego at the Grand Hyatt

View IR Calendar

Email Alerts

Sign up for email alerts for Press Releases & SEC Filings